Short-Chain Dehydrogenases in Retinol/Sterol Metabolism

视黄醇/甾醇代谢中的短链脱氢酶

基本信息

项目摘要

All-trans-retinoic acid (RA) is the bioactive derivative of vitamin A and β-carotene that is essential for differentiation and development of embryonic tissues as well as the maintenance and robust performance of adult organs and tissues. In the nucleus, RA acts by binding to RXR/RAR heterodimeric transcription factors to regulate the expression of over 530 genes. RA is also known to have regulatory functions in the cytoplasm. During embryogenesis the levels of RA change in a strictly defined spatiotemporal pattern. Similarly, during adulthood the concentration of RA in various tissues and cells is maintained within narrow margins that are optimal for each type of cell. Disruption of RA homeostasis results in embryonic malformations, whereas in adult tissues aberrations in RA homeostasis can lead to pathophysiological changes that result in disease. Thus, it is critical to understand: (1) the molecular mechanisms whereby the cells maintain RA homeostasis; (2) how the cells adjust RA levels in response to varied physiological requirements; and (3) why these mechanisms fail in disease. Since the oxidation of retinol to retinaldehyde is the rate-limiting step in the pathway of RA biosynthesis that controls the overall rate of RA biosynthesis, it is important to identify and characterize the enzymes that catalyze this step and to understand the contribution of each enzyme to overall RA homeostasis. During the previous funding cycle, it was established that the baseline levels of RA in cells are maintained by a heterooligomeric retinoid oxidoreductase complex (ROC) formed by retinol dehydrogenase 10 (RDH10) and dehydrogenase/reductase 3 (DHRS3). Data from this and other laboratories indicate that RDH10 is also the primary enzyme responsible for the oxidation of retinol to retinaldehyde during early stages of embryogenesis. However, other yet unidentified retinol dehydrogenases appear to be more important in adult tissues. Preliminary data from this laboratory indicate that mice with a double knockout of genes encoding retinol dehydrogenase epidermal 2 (RDHE2) and RDHE2-similar (RDHE2S), display a phenotype consistent with reduced RA signaling in skin pilosebaceous unit and meibomian glands of eyelids. The data also suggest that the expression of RDHE2 and RDHE2S oscillates in a diurnal pattern and during various stages of hair follicle regeneration. We hypothesize that these inducible and RA-sensitive enzymes are responsible for the fluctuations of RA during the cycle of hair follicle regeneration, and for fine-tuning of the baseline RA levels, established by the ROC, in response to varied physiological requirements or pathophysiological conditions. To test this hypothesis, we will use the novel mouse models and custom-made antibodies generated during the previous cycle to determine the contribution of RDHE2/E2S to RA biosynthesis in skin and meibomian glands of the eyelid. The proposed studies will provide a comprehensive background to better understand the molecular mechanisms that maintain and/or disrupt RA homeostasis and will inform future strategies to develop targeted and more effective therapeutic interventions.
全反式维甲酸(全反式维甲酸,RA)是维生素A和β-胡萝卜素的生物活性衍生物,对胚胎组织的分化和发育以及成人器官和组织的维持和强健性能是必不可少的。在细胞核中,RA通过与RXR/RAR异二聚体转录因子结合来调控超过530个基因的表达。已知RA在细胞质中也具有调节功能。在胚胎发育过程中,RA水平以严格定义的时空模式变化。类似地,在成年期间,各种组织和细胞中的维甲酸浓度维持在对每种类型的细胞都最适宜的狭窄范围内。RA动态平衡的破坏会导致胚胎畸形,而在成人组织中,RA动态平衡的异常会导致病理生理变化,从而导致疾病。因此,重要的是要了解:(1)细胞维持RA动态平衡的分子机制;(2)细胞如何调节RA水平以响应不同的生理需求;以及(3)为什么这些机制在疾病中失败。由于视黄醇的氧化为视黄醛是 对于控制RA生物合成总速率的RA生物合成途径,重要的是鉴定和表征催化这一步骤的酶,并了解每个酶对整体RA动态平衡的贡献。在前一个资金周期中,细胞中RA的基线水平是由视黄醇脱氢酶10(RDH10)和脱氢酶/还原酶3(DHRS3)形成的异寡体维甲酸氧化还原酶复合体(ROC)维持的。来自该实验室和其他实验室的数据表明,在胚胎发育的早期阶段,RDH10也是负责将视黄醇氧化为视黄醛的主要酶。然而,其他尚未确定的视黄醇脱氢酶似乎在成人组织中更重要。该实验室的初步数据显示,编码视黄醇脱氢酶表皮2(RDHE2)和类似RDHE2(RDHE2S)的基因双重敲除的小鼠,在皮肤毛皮脂腺单位和眼睑眉板腺中表现出与RA信号减少一致的表型。数据还表明,RDHE2和RDHE2S的表达在毛囊再生的不同阶段以昼夜模式振荡。我们推测,这些可诱导的和RA敏感的酶负责在毛囊再生周期中RA的波动,并微调由中华民国建立的基线RA水平,以响应不同的生理要求或 病理生理条件。为了验证这一假设,我们将使用新的小鼠模型和在前一个周期中产生的定制抗体来确定RDHE2/E2S对皮肤和眼睑眉板腺中RA生物合成的贡献。拟议的研究将提供一个全面的背景,以更好地了解维持和/或破坏RA动态平衡的分子机制,并将为未来开发有针对性的、更有效的治疗干预措施提供信息。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Natalia Y Kedishvili其他文献

Natalia Y Kedishvili的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Natalia Y Kedishvili', 18)}}的其他基金

Hepatic retinoid metabolism and signaling in starvation and diabetes.
饥饿和糖尿病中的肝脏类维生素A代谢和信号传导。
  • 批准号:
    10394793
  • 财政年份:
    2021
  • 资助金额:
    $ 44.49万
  • 项目类别:
Hepatic retinoid metabolism and signaling in starvation and diabetes.
饥饿和糖尿病中的肝脏类维生素A代谢和信号传导。
  • 批准号:
    10541248
  • 财政年份:
    2021
  • 资助金额:
    $ 44.49万
  • 项目类别:
Hepatic retinoid metabolism and signaling in starvation and diabetes.
饥饿和糖尿病中的肝脏类维生素A代谢和信号传导。
  • 批准号:
    10116152
  • 财政年份:
    2021
  • 资助金额:
    $ 44.49万
  • 项目类别:
Short-Chain Dehydrogenases in Retinol/Sterol Metabolism
视黄醇/甾醇代谢中的短链脱氢酶
  • 批准号:
    9916119
  • 财政年份:
    2020
  • 资助金额:
    $ 44.49万
  • 项目类别:
Short-Chain Dehydrogenases in Retinol/Sterol Metabolism
视黄醇/甾醇代谢中的短链脱氢酶
  • 批准号:
    10545743
  • 财政年份:
    2020
  • 资助金额:
    $ 44.49万
  • 项目类别:
Project 3: Molecular Targets of Rexinoid Action in Skin
项目 3:Rexinoid 在皮肤中作用的分子靶标
  • 批准号:
    10007600
  • 财政年份:
    2017
  • 资助金额:
    $ 44.49万
  • 项目类别:
Project 3: Molecular Targets of Rexinoid Action in Skin
项目 3:Rexinoid 在皮肤中作用的分子靶标
  • 批准号:
    10263924
  • 财政年份:
    2017
  • 资助金额:
    $ 44.49万
  • 项目类别:
SHORT-CHAIN DEHYDROGENASES IN RETINOL/STEROL METABOLISM
视黄醇/甾醇代谢中的短链脱氢酶
  • 批准号:
    8460307
  • 财政年份:
    2012
  • 资助金额:
    $ 44.49万
  • 项目类别:
Short-Chain Dehydrogenases in Retinol/Sterol Metabolism
视黄醇/甾醇代谢中的短链脱氢酶
  • 批准号:
    7809737
  • 财政年份:
    2009
  • 资助金额:
    $ 44.49万
  • 项目类别:
Short-Chain Dehydrogenases in Retinol/Sterol Metabolism
视黄醇/甾醇代谢中的短链脱氢酶
  • 批准号:
    7856985
  • 财政年份:
    2009
  • 资助金额:
    $ 44.49万
  • 项目类别:

相似海外基金

SYNTHESIS AND BIOLOGICAL ACTIVITY OF A NEW ALL-TRANS-RETINOL METABOLITES
一种新的全反式视黄醇代谢物的合成和生物活性
  • 批准号:
    8361148
  • 财政年份:
    2011
  • 资助金额:
    $ 44.49万
  • 项目类别:
SYNTHESIS AND BIOLOGICAL ACTIVITY OF A NEW ALL-TRANS-RETINOL METABOLITES
一种新的全反式视黄醇代谢物的合成和生物活性
  • 批准号:
    8168931
  • 财政年份:
    2010
  • 资助金额:
    $ 44.49万
  • 项目类别:
SYNTHESIS AND BIOLOGICAL ACTIVITY OF A NEW ALL-TRANS-RETINOL METABOLITES
一种新的全反式视黄醇代谢物的合成和生物活性
  • 批准号:
    7954594
  • 财政年份:
    2009
  • 资助金额:
    $ 44.49万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了